Kenya, Slovenia step up fight against drug-resistant infections
Health & Science
By
Noel Nabiswa
| Oct 06, 2026
Kenya and Slovenia are strengthening scientific cooperation to tackle the growing threat of antimicrobial resistance, with researchers exploring bacteriophages as a potential tool against drug-resistant infections.
Speaking at the Africa Bacteriophage Summit Nairobi 2026, Slovenia’s non-resident Ambassador to Kenya, Kristina Radej, said stronger cooperation in research, clinical practice and regulation was needed to address infections that are increasingly difficult to treat with conventional antibiotics.
The summit has brought together health experts, researchers, clinicians, regulators, universities and public institutions from Kenya, Slovenia and other countries to examine the potential of bacteriophage technology in the fight against antimicrobial resistance.
Bacteriophages are viruses that specifically target and destroy bacteria. Scientists are increasingly studying their potential use in treating bacterial infections as resistance to existing antibiotics continues to grow.
READ MORE
Unilever invests Sh70m in solar to cut energy costs
Safaricom unveils Shari'ah compliant Ziidi MMF
Ruto unveils Sh390bn Geely electric mobility plan
Kenya seeks private investors to fund 61 per cent of Sh598bn irrigation plan
Kenyans can now buy into Dangote's Sh207 billion IPO after CMA nod
IFC backs Quickmart IPO with Sh1.9bn investor commitment
Risks of Kenya's off-book debt as State ramps up securitisation drive
How State blunders cost Kwale decade-long titanium boom
Coffee societies net Sh41 billion in one year
AfDB, Family Bank sign Sh1.297b trade deal to support Kenyan businesses
The meeting is examining the clinical, regulatory, ethical and patient-safety requirements for the use of bacteriophages, while also exploring their potential applications in agriculture, livestock and food production.
Radej said Kenya and Slovenia were seeking to strengthen joint research, training and institutional links between hospitals, universities, laboratories, regulators and veterinary and agricultural institutions.
She said antimicrobial resistance, climate change, changing ecosystems and health security were complex challenges that could not be addressed by individual countries acting alone.
“For us, scientific cooperation is not supplementary to foreign policy; it is integral to it,” she said.
Radej said Slovenia was keen to use its scientific and technological expertise to deepen cooperation with Kenya and the wider East African region in biotechnology, medicine, artificial intelligence and environmental research.
She said science diplomacy could help ensure that advances in biotechnology and digital technologies were developed responsibly while supporting stronger health systems and regional resilience.
The summit is also examining how bacteriophage research can support Kenya’s antimicrobial resistance priorities across human health, livestock and food systems under the One Health approach.
The approach recognises the close links between human, animal and environmental health and is increasingly being used to guide efforts to address antimicrobial resistance.
Representing the Food and Agriculture Organisation of the United Nations, FAO officials said antimicrobial resistance was not only a health challenge but also a threat to food security, livelihoods, environmental sustainability and economic growth.
FAO said antimicrobial use in agrifood systems is often linked to underlying challenges including high disease burdens, inadequate biosecurity, limited access to animal health services and diagnostics, and weak surveillance systems.
The organisation said strengthening disease prevention, animal health, biosecurity and sustainable production practices would be critical in reducing dependence on antimicrobials.
FAO also highlighted bacteriophages as an emerging technology that could complement existing interventions across human health, animal health, food production and environmental management.
However, the organisation stressed that innovation must be supported by scientific evidence, appropriate regulatory frameworks, quality assurance, research and strategic partnerships.
Participants are expected to discuss the evidence required to determine where and how bacteriophage-based therapies can be safely introduced, as well as the regulatory pathways needed before their wider use.
Radej called for stronger laboratory capacity, evidence-based policies and harmonised regulatory frameworks to support the safe development and application of new technologies in tackling antimicrobial resistance.
She said closer cooperation between Kenya and Slovenia could strengthen the region’s capacity to respond to drug-resistant infections while creating opportunities for innovation, skills development and scientific research.
The summit is also providing a platform for researchers and institutions to identify areas for joint projects, knowledge exchange and capacity building.
The meeting, being held in Nairobi, includes participation from Kenyan health institutions, including Kenyatta National Hospital, government agencies, researchers and international partners.
The discussions are expected to contribute to efforts to develop new tools for preventing and treating bacterial infections while ensuring emerging technologies meet appropriate clinical, ethical and regulatory standards.